EPISODE: Exploring Clinical Predictors of COPD Exacerbation in a Community Cohort
Study Details
Study Description
Brief Summary
The aim of our study is to assess the feasibility and benefits of the implementation of an interactive telemonitoring system for earlier detection of COPD exacerbations in a community cohort preventing further deterioration requiring hospital admissions.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
No Intervention: Usual follow up Group 1: To keep follow-up in their usual family practice/ pulmonology consultations |
|
Experimental: Home telemonitoring Group 2: To keep follow-up in their usual family practice/ pulmonology consultations and associate an interactive home telemonitoring system managed by the researchers. |
Other: Experimental
Patients will be every two weeks monitored by the researchers' team, taking into consideration lung function, symptoms, physical activity, pulse oximetry, body temperature, need for relief medication and Sputum characteristics. Over the 18 months, they will be the target of health education interventions, 2 individual and 2 in group.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Number of COPD exacerbation with hospital admission [18 months]
- Number of COPD exacerbation managed at home [18 months]
- Quality of Life using St. George's Respiratory Questionnaire [18 months]
Scores range from 0 (no effect on quality of life) to a maximum score of 100 (maximum perceived distress). A higher score means a poorer quality of life
- Impact of COPD on patient's life using COPD Assessment Test (CAT) [18 months]
Range of CAT scores from 0-40. Higher scores denote a more severe impact of COPD on a patient's life.
- Impact of the programme - rate of compliance [18 months]
Measurement tool - questionnaire
- Impact of the programme - satisfaction level [18 months]
Measurement tool - questionnaire
- Impact of the programme - % of retention of participating patients [18 months]
Measurement tool - questionnaire
Secondary Outcome Measures
- Pulmonary function (FEV1 and FEV1/ FVC ratio after BD) [18 months]
- Dyspnoea level (mMRC) [18 months]
- Changes in GOLD classification [18 months]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Diagnosis of COPD
-
Aged 40 years or above
-
Must be enrolled in health centres from Braga
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University of Minho
- GlaxoSmithKline
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ISS 10805